Karim Damji, Saama’s Senior Vice President of Marketing is quoted:

“Such state-of-the-art platforms are a gateway to a new era of clinical development, one in which structured and unstructured data is integrated, curated, and animated in unprecedented fashion for actionable business insights that safely and effectively speed the development of new drugs. Increased efficiencies and cost savings will be realized in relation to critical outcomes such as patient recruitment, investigator identification, protocol adherence, inclusion/exclusion criteria, prediction of study success, continuous process improvement, and the ability to leverage previously untapped sources of data.”

Read more about Saama as part of the Hope of new Technologies that provide actionable insights through AI-enabled clinical data analytics.

The post The Giddy Hope of New Technologies on PM360 appeared first on Saama Technologies.